---
schema_version: "secwatch.filing_event.v1"
accession: "0001688757-25-000050"
form_type: "8-K"
ticker: "ESTA"
cik: "0001688757"
company_name: "ESTABLISHMENT LABS HOLDINGS INC."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:48:34.678105+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Motiva USA update: >1,000 surgeons, Q2 sales guide $9.5-10M, reconstruction filing Q4 2025

## Summary
- Over 1,000 surgeons now offer Motiva implants in the United States.
- Q2 2025 Motiva US sales expected $9.5M–$10M (partial quarter).
- Company to seek US FDA approval for Motiva reconstruction use in Q4 2025.
- Preservé US launch anticipated in first half of 2026.

## SEC filing metadata
- accession: 0001688757-25-000050
- form_type: 8-K
- ticker: ESTA
- cik: 0001688757
- company_name: ESTABLISHMENT LABS HOLDINGS INC.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1688757/000168875725000050/0001688757-25-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1688757/000168875725000050/esta-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001688757-25-000050
- JSON: https://secwatch.observer/filing/0001688757-25-000050.json
- Plain text: https://secwatch.observer/filing/0001688757-25-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.